Elan Corporation, plc (ELN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stonesouls who wrote (993)	6/28/2000 8:52:00 AM
From: William Partmann	of 10345

Elan gets FDA "approvable letter" for ziconotide DUBLIN, June 28 (Reuters) - International pharmaceutical company Elan (quote from Yahoo! UK & Ireland: ELA.L) (NYSE:ELN - news) said on Wednesday it had received an ``approvable letter'' from the U.S. Food and Drug Administration for its ziconotide chronic pain treatment. A company spokeswoman said such a move meant that the FDA was prepared to move ahead with the approval process but that there were several issues to be finalised before the product could be launched to market. She was, however, unable to specify the issues to be addressed. Elan CEO Donal Geaney said he was pleased to have received the FDA letter. ``We would like to thank the FDA for promptly responding to our application and look forward to working with them to complete the approval process,'' he said in a statement.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next